{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:54:55Z","timestamp":1794534895726,"version":"4.9.1"},"reference-count":52,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,10,6]],"date-time":"2010-10-06T00:00:00Z","timestamp":1286323200000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction Biology"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Ibogaine is a naturally occurring alkaloid that has been reported to decrease various adverse phenotypes associated with exposure to drugs of abuse and alcohol in human and rodent models. Unfortunately, ibogaine cannot be used as a medication to treat addiction because of severe side effects. Previously, we reported that the desirable actions of ibogaine to reduce self\u2010administration of, and relapse to, alcohol consumption are mediated via the upregulation of the expression of the glial cell line\u2010derived neurotrophic factor (GDNF) in the midbrain ventral tegmental area (VTA), and the consequent activation of the GDNF pathway. The ibogaine metabolite, noribogaine, and a synthetic derivative of ibogaine, 18\u2010Methoxycoronaridine (18\u2010MC), possess a similar anti\u2010addictive profile as ibogaine in rodent models, but without some of its adverse side effects. Here, we determined whether noribogaine and\/or 18\u2010MC, like ibogaine, increase<jats:italic>GDNF<\/jats:italic>expression, and whether their site of action to reduce alcohol consumption is the VTA. We used SH\u2010SY5Y cells as a cell culture model and found that noribogaine, like ibogaine, but not 18\u2010MC, induces a robust increase in<jats:italic>GDNF<\/jats:italic>mRNA levels. Next, we tested the effect of intra\u2010VTA infusion of noribogaine and 18\u2010MC on rat operant alcohol self\u2010administration and found that noribogaine, but not 18\u2010MC, in the VTA decreases responding for alcohol. Together, our results suggest that noribogaine and 18\u2010MC have different mechanisms and sites of action.<\/jats:p>","DOI":"10.1111\/j.1369-1600.2010.00251.x","type":"journal-article","created":{"date-parts":[[2010,10,6]],"date-time":"2010-10-06T18:44:03Z","timestamp":1286390643000},"page":"424-433","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Noribogaine, but not 18\u2010MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self\u2010administration"],"prefix":"10.1111","volume":"15","author":[{"given":"Sebastien","family":"Carnicella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao\u2010Yao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinn V.","family":"Yowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley D","family":"Glick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorit","family":"Ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,6]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06687.x"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2007.08.034"},{"key":"e_1_2_7_4_1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3565(24)29567-7","article-title":"In vivo neurobiological effects of ibogaine and its O\u2010desmethyl metabolite, 12\u2010hydroxyibogamine (noribogaine), in rats","volume":"297","author":"Baumann MH","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90212-Z"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-4328(94)90080-9"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2008.12.022"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alcohol.2008.12.001"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711755105"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2008.12.001"},{"key":"e_1_2_7_11_1","first-page":"S15","article-title":"The state of pharmacotherapy for the treatment of alcohol dependence","volume":"36","author":"Garbutt JC","year":"2009","journal-title":"J Subst Abuse Treat"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(96)00056-X"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)90948-2"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb08237.x"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)01944-1"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)01284-0"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb05211.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)01563-9"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.03.045"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(92)90089-8"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.09.038"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3959-04.2005"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-6394fje"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M706216200"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2009.02.001"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2007.08.005"},{"key":"e_1_2_7_27_1","volume-title":"Design and Analysis: A Researcher's Handbook","author":"Keppel G","year":"1991"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-05-01452.2001"},{"key":"e_1_2_7_29_1","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/medicina44120123","article-title":"Acute toxicity of ibogaine and noribogaine","volume":"44","author":"Kubiliene A","year":"2008","journal-title":"Medicina (Kaunas)"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2006.02.050"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/0960327107087802"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(03)00119-9"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb08242.x"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb05213.x"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(95)00273-9"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(96)00739-1"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(86)90347-1"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(93)90500-F"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-22-08828.1997"},{"key":"e_1_2_7_40_1","first-page":"764","article-title":"Cytochrome P4502D6 catalyzes the O\u2010demethylation of the psychoactive alkaloid ibogaine to 12\u2010hydroxyibogamine","volume":"26","author":"Obach RS","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_7_41_1","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos G","year":"2007"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2002.00951.x"},{"key":"e_1_2_7_43_1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0031-6997(25)06842-5","article-title":"100 years of ibogaine: neurochemical and pharmacological actions of a putative anti\u2010addictive drug","volume":"47","author":"Popik P","year":"1995","journal-title":"Pharmacol Rev"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(99)00024-6"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(95)00152-M"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(97)10003-X"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(94)90105-8"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199009000-00005"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(94)90049-3"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.3109\/03602539109029764"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245936"},{"key":"e_1_2_7_52_1","first-page":"3099","article-title":"Addiction treatment strives for legitimacy","volume":"288","author":"Vastag B","year":"2002","journal-title":"JAMA"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/03602530701836712"}],"container-title":["Addiction Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1369-1600.2010.00251.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1369-1600.2010.00251.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T10:37:05Z","timestamp":1740566225000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1369-1600.2010.00251.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1111\/j.1369-1600.2010.00251.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1369-1600.2010.00251.x","archive":["Portico"],"relation":{},"ISSN":["1355-6215","1369-1600"],"issn-type":[{"value":"1355-6215","type":"print"},{"value":"1369-1600","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"2010-10-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}